A PYMNTS Company

US: Senate to examine drug prices Tuesday

 |  February 24, 2019

US drugmaker Merck stated that its CEO Ken Frazier plans to testify at a Senate hearing Tuesday, February 26.

Republican Senator Chuck Grassley, chairman of the Senate Finance Committee, and Democratic Senator Ron Wyden, ranking member of the committee invited executives from seven pharmaceutical companies, including Merck, to testify. The others are AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, and Sanofi.

Congress has been targeting the pharmaceutical industry over the rising cost of prescription drugs for US consumers, particularly since Democrats took over the House of Representatives in January.

Full Content: CT Mirror

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.